MSMO1, a typical target of cholesterol biosynthesis, has been discovered to be up-regulated in correlation with drug resistance, tumor cell proliferation, and suppression of apoptosis in several cancers [54,55]. This evidence concerns the gene MSMO1 and neoplasm.